Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2019-06-12 History
Report ID 63646
Drug Identification Number 00328154
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name Atropine Sulfate Injection USP
Company Name PFIZER CANADA ULC
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 0.1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 5mL LifeShield
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-21
Estimated end date 2019-10-18
Actual end date
Shortage status Actual shortage
Updated date 2019-06-12
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2019-06-12 French Compare
v20 2019-06-12 English Compare
v19 2019-02-26 French Compare
v18 2019-02-26 English Compare
v17 2019-01-16 French Compare
v16 2019-01-16 English Compare
v15 2018-12-22 English Compare
v14 2018-12-21 French Compare
v13 2018-12-21 English Compare
v12 2018-12-21 English Compare
v11 2018-12-17 French Compare
v10 2018-12-17 English Compare
v9 2018-12-08 English Compare
v8 2018-11-19 French Compare
v7 2018-11-19 English Compare
v6 2018-10-23 French Compare
v5 2018-10-23 English Compare
v4 2018-10-16 French Compare
v3 2018-10-16 English Compare
v2 2018-10-10 French Compare

Showing 1 to 20 of 21